The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of programmed death 1 (PD-1) and programmed death 1 ligand (PD-L1) inhibitors in patients with FGFR mutations and gene fusions: Results from a data analysis of an ongoing phase 2 study of erdafitinib (JNJ-42756493) in patients (pts) with advanced urothelial cancer (UC).
 
Arlene O. Siefker-Radtke
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; EMD Serono; Genentech; Inovio Pharmaceuticals; Janssen; Lilly; Merck; NCCN
Speakers' Bureau - Genentech
Research Funding - Bristol-Myers Squibb; Janssen; Michael and Sherry Sutton Fund for Urothelial Cancer; NIH; Takeda
Patents, Royalties, Other Intellectual Property - Methods of characterizing and treating molecular subsets of muscle-invasive bladder cancer.
 
Andrea Necchi
Consulting or Advisory Role - AstraZeneca; Bayer; Clovis Oncology; Merck Sharp & Dohme; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pierre Fabre; Roche
 
Eli Rosenbaum
No Relationships to Disclose
 
Stephane Culine
Consulting or Advisory Role - Janssen; Merck; Roche
 
Earle Frederick Burgess
Stock and Other Ownership Interests - Becton Dickinson; Calithera Biosciences; Exelixis; Gilead Sciences; Ignyta; Johnson & Johnson; McKesson; Medtronic
Consulting or Advisory Role - Bayer; Janssen; Pfizer; Roche/Genentech
Speakers' Bureau - Exelixis; Roche/Genentech
Research Funding - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - Exelixis; Pfizer; Roche/Genentech
 
Peter H. O'Donnell
Stock and Other Ownership Interests - Allergan; PrescriptIQ
Honoraria - Algeta ASA; American Medical Forum; Astellas Pharma; AstraZeneca; Genentech/Roche; Harrison Consulting Group; Inovio Pharmaceuticals; Janssen Biotech; Kantar Health; Merck; Novartis; Parexel; Quintiles; Seagen; Xcenda
Research Funding - Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); Janssen (Inst); Merck (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Named as co-inventor on a pending patent for a genomic prescribing system for medication prescribing.
Expert Testimony - TERA; Triage Cancer
Other Relationship - Advance Medical
 
Scott T. Tagawa
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Dendreon; Endocyte; Genentech; Immunomedics; Janssen; Karyopharm Therapeutics; Medivation; Sanofi; Tolmar
Speakers' Bureau - Amgen
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Endocyte (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst)
Travel, Accommodations, Expenses - Immunomedics; Sanofi
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Castle Biosciences; Eisai; Roche/Genentech
Travel, Accommodations, Expenses - Newlink Genetics
 
Anne OHagan
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Anjali Narayan Avadhani
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Bob Zhong
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Ademi E. Santiago-Walker
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Tito Roccia
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Yohann Loriot
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Ipsen; Janssen; Merck Sharp & Dohme; Roche; Sanofi
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck Sharp & Dohme; Roche